Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Contact information

Email
ruth.coleman@ocdem.ox.ac.uk

Telephone
+44 (0)1865 857253

Website
http://www.dtu.ox.ac.uk/staff/RuthColeman.php

Research groups

Holman Group: Diabetes Trials Unit

Ruth Coleman

MSc

Senior Research Statistician

Recent publications

Baseline characteristics and temporal differences in Acarbose Cardiovascular Evaluation (ACE) trial participants.
Journal article

Theodorakis MJ. et al, (2018), Am Heart J, 199, 170 - 175
Modelling incremental benefits on complications rates when targeting lower HbA1c levels in people with Type 2 diabetes and cardiovascular disease.
Journal article

Mostafa SA. et al, (2018), Diabet Med, 35, 72 - 77
Health selection into neighborhoods among patients enrolled in a clinical trial.
Journal article

Arcaya MC. et al, (2017), Prev Med Rep, 8, 51 - 54
Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial.
Journal article

Holman RR. et al, (2017), Lancet Diabetes Endocrinol, 5, 877 - 886
Association Between More Intensive vs Less Intensive Blood Pressure Lowering and Risk of Mortality in Chronic Kidney Disease Stages 3 to 5: A Systematic Review and Meta-analysis.
Journal article

Malhotra R. et al, (2017), JAMA Intern Med, 177, 1498 - 1505

More publications